GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.
Business Model:
Revenue: $0
Employees: 1-10
Address: -
City: Raleigh
State: NC
Zip: 27513
Country: US
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders. With or without inhibitors, its flagship program, GENV-HEM, is the first universal gene therapy treatment for hemophilias A and B. The National Hemophilia Foundation has written a letter of support for GENV-HEM and the FDA has designated it as an orphan drug. A further gene therapy is being developed by GeneVentiv for Hemophilia Arthropathy, a degenerative joint disease that affects about 50% of hemophilia patients.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2022 | Grant | 1 | $50k |
Innovate Carolina Innovate Carolina |
8/2022 | Venture Round | $1.4M | 7/2022 | Equity | $1.4M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|